Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Targeted Naltrexone for Early Problem Drinkers
NCT00000455Phase 4Completed
- Sponsor
- UConn Health
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of naltrexone in alcohol use disorder (AUD) (4 arms), sponsored by UConn Health. Status: completed.
02
Drugs
naltrexone
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT00000455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000455.